Dairy calcium intake and lifestyle risk factors for bone loss in hiv-infected and uninfected mediterranean subjects

BMC Infectious Diseases

Volumn 12, Issue , 2012, Pages

  Vecchi, Valentina L ^a   Soresi, Maurizio ^a   Giannitrapani, Lydia ^a   Mazzola, Giovanni ^b   La Sala, Sara ^a   Tramuto, Fabio ^a   Caruso, Giuseppe ^a   Colomba, Claudia ^a   Mansueto, Pasquale ^a   Madonia, Simona ^a   Montalto, Giuseppe ^a   Di Carlo, Paola ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

Author keywords

Bone mineral density; Dairy intake; HIV; Osteopenia; Osteoporosis

Indexed keywords

25 HYDROXYVITAMIN D; ALKALINE PHOSPHATASE BONE ISOENZYME; ANTIRETROVIRUS AGENT; CALCIUM; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PHOSPHORUS; PROTEINASE INHIBITOR; TENOFOVIR; VIRUS RNA; VITAMIN D;

ADULT; AGE; ARTICLE; BONE DENSITY; BONE DISEASE; BONE TURNOVER; CALCIUM INTAKE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DRUG DEPENDENCE; DUAL ENERGY X RAY ABSORPTIOMETRY; EATING HABIT; ENVIRONMENTAL FACTOR; ETHNIC GROUP; FEMALE; FEMUR NECK; FRACTURE; FRAX SCORE; HEPATITIS C; HIP FRACTURE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIFESTYLE; LIFESTYLE MODIFICATION; LUMBAR SPINE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL ANALYSIS; MEDITERRANEAN; MIXED INFECTION; OSTEOLYSIS; OSTEOPENIA; OSTEOPOROSIS; PREVALENCE; QUESTIONNAIRE; RATING SCALE; RISK FACTOR; VITAMIN BLOOD LEVEL;

ABSORPTIOMETRY, PHOTON; ADULT; BONE DENSITY; CALCIUM; CASE-CONTROL STUDIES; DIET; FEMALE; HIV INFECTIONS; HUMANS; LIFE STYLE; MALE; MEDITERRANEAN REGION; MIDDLE AGED; OSTEOPOROSIS; QUESTIONNAIRES; RISK FACTORS;

EID: 84866402544     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-12-192     Document Type: Article

References (53)

1. Mansky KC. Aging, human immunodeficiency virus, and bone health. Clin Interv Aging 2010, 5:285-292. 2946855, 20924437.
2. Luxon BA. Bone disorders in chronic liver diseases. Curr Gastroenterol Rep 2011, 13:40-48. 10.1007/s11894-010-0166-4, 21104208.
3. Goel V, Kar P. Hepatic osteodystrophy. Trop Gastroenterol 2010, 31:82-86.
4. Mazziotti G, Bianchi A, Bonadonna S, Cimino V, Patelli I, Fusco A, Pontecorvi A, De Marinis L, Giustina A. Prevalence of vertebral fractures in men with acromegaly. J Clin Endocrinol Metab 2008, 93:4649-4655. 10.1210/jc.2008-0791, 18827004.
5. Mancini T, Mazziotti G, Doga M, Carpinteri R, Simetovic N, Vescovi PP, Giustina A. Vertebral fractures in males with type 2 diabetes treated with rosiglitazone. Bone 2009, 45:784-788. 10.1016/j.bone.2009.06.006, 19527806.
6. Martin TJ. Paracrine regulation of osteoclast formation and activity: milestones in discovery. J Musculoskelet Neuronal Interact 2004, 4:243-253.
7. Lima AL, de Oliveira PR, Plapler PG, Marcolino FM, de Souza Meirelles E, Sugawara A, Gobbi RG, Dos Santos AL, Camanho GL. Osteopenia and osteoporosis in people living with HIV: multiprofessional approach. HIV AIDS (Auckl) 2011, 3:117-124.
8. Musumeci M, Vadalà G, Tringali G, Insirello E, Roccazzello AM, Simpore J, Musumeci S. Genetic and environmental factors in human osteoporosis from Sub-Saharan to Mediterranean areas. J Bone Miner Metab 2009, 27:424-434. 10.1007/s00774-009-0041-2, 19255718.
9. Carmina E, Di Fede G, Napoli N, Renda G, Vitale G, Lo Pinto C, Bruno D, Malizia R, Rini GB. Hypogonadism and hormone replacement therapy on bone mass of adult women with thalassemia major. Calcif Tissue Int 2004, 74:68-71.
10. Alberti KG, Zimmet P, Shaw J, , . IDF epidemiology task force consensus group, IDF epidemiology task force consensus group The metabolic syndrome-a new worldwide definition. Lancet 2005, 366:1059-1061. 10.1016/S0140-6736(05)67402-8, 16182882, IDF epidemiology task force consensus group, IDF epidemiology task force consensus group.
11. Varenna M, Binelli L, Casari S, Zucchi F, Sinigaglia L. Effects of dietary calcium intake on body weight and prevalence of osteoporosis in early postmenopausal women. Am J Clin Nutr 2007, 86:639-644.
12. Carnovale E, Marletta L. Food composition tables 1997, Italian National Institute of Nutrition, Rome.
13. Krogh V, Freudenheim JL, D'Amicis A. Food sources of nutrients of the diet of elderly Italians: II Micronutrients. Int J Epidemiol 1993, 22:869-877. 10.1093/ije/22.5.869, 8282466.
14. Bonura F, Tramuto F, Vitale F, Perna AM, Viviano E, Romano N, , . Group for HIV-1 Antiretroviral Studies in Sicily, Group for HIV-1 Antiretroviral Studies in Sicily Transmission of drug-resistant HIV type 1 strains in HAART-naive patients: a 5-year retrospective study in Sicily, Italy. AIDS Res Hum Retroviruses 2010, 26:961-965. 10.1089/aid.2009.0250, 20707733, Group for HIV-1 Antiretroviral Studies in Sicily, Group for HIV-1 Antiretroviral Studies in Sicily.
15. Focà E, Motta D, Borderi M, Gotti D, Albini L, Calabresi A, Izzo I, Bellagamba R, Narciso P, Sighinolfi L, Clò A, Gibellini D, Quiros-Roldan E, Brianese N, Cesana BM, Re MC, Torti C. Prospective evaluation of bone markers, parathormone and 1,25-(OH)2 vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir/ritonavir or efavirenz. BMC Infect Dis 2012, 12:38. 10.1186/1471-2334-12-38, 3296645, 22333484.
16. Carmina E, Bucchieri S, Esposito A, Del Puente A, Mansueto P, Di Fede G, Rini GB. Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistance. J Clin Endocrinol Metab 2007, 92:2500-2505. 10.1210/jc.2006-2725, 17405838.
17. Report of a WHO Study Group Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. World Health Organ Tech Rep Ser 1994, 843:1-129. Report of a WHO Study Group.
18. National Osteoporosis Foundation Clinician's Guide to Prevention and Treatment of Osteoporosis 2010, National Osteoporosis Foundation, Washington, DC, National Osteoporosis Foundation.
19. Berry SD, Kiel DP, Donaldson MG, Cummings SR, Kanis JA, Johansson H, Samelson EJ. Application of the National Osteoporosis Foundation Guidelines to postmenopausal women and men: the Framingham Osteoporosis Study. Osteoporos Int 2010, 21:53-60. 10.1007/s00198-009-1127-3, 2889692, 19937426.
20. FRAX: WHO fracture risk assessment tool http://www.shef.ac.uk/FRAX/.
21. Smit E, Graham NM, Tang A, Flynn C, Solomon L, Vlahov D. Dietary intake of community-based HIV-1 seropositive and seronegative injecting drug users. Nutrition 1996, 12:496-501. 10.1016/S0899-9007(96)91726-8, 8878141.
22. Leite LH, Sampaio AB. Dietary calcium, dairy food intake and metabolic abnormalities in HIV-infected individuals. J Hum Nutr Diet 2010, 23:535-543. 10.1111/j.1365-277X.2010.01068.x, 20831710.
23. Jacobson DL, Spiegelman D, Duggan C, Weinberg GA, Bechard L, Furuta L, Nicchitta J, Gorbach SL, Miller TL. Predictors of bone mineral density in human immunodeficiency virus-1 infected children. J Pediatr Gastroenterol Nutr 2005, 41:339-346. 10.1097/01.mpg.0000174468.75219.30, 16131991.
24. Lau EM, Suriwongpaisal P, Lee JK, De Das S, Festin MR, Saw SM, Khir A, Torralba T, Sham A, Sambrook P. Risk factors for hip fracture in Asian men and women: the Asian osteoporosis study. J Bone Miner Res 2001, 16:572-580. 10.1359/jbmr.2001.16.3.572, 11277276.
25. Jha RM, Mithal A, Malhotra N, Brown EM. Pilot case-control investigation of risk factors for hip fractures in the urban Indian population. BMC Musculoskelet Disord 2010, 11:49. 10.1186/1471-2474-11-49, 2845554, 20226091.
26. Johnell O, Gullberg B, Kanis JA, Allander E, Elffors L, Dequeker J, Dilsen G, Gennari C, Lopes Vaz A, Lyritis G. Risk factors for hip fracture in European women: the MEDOS Study. Mediterranean Osteoporosis Study. J Bone Miner Res 1995, 10:1802-1815.
27. Sahni S, Tucker KL, Kiel DP, Quach L, Casey V, Hannan MT. Positive Association of Total Dairy and Milk Intake with Bone Mineral Density (BMD): Results from the Framingham Offspring Study 2011, The American Society for Bone and Mineral Research, Annual Meeting, San Diego, 19 September.
28. Sjögren K, Engdahl C, Henning P, Lerner UH, Tremaroli V, Lagerquist MK, Bäckhed F, Ohlsson C. The gut microbiota regulates bone mass in mice. J Bone Miner Res 2012, 27:1357-1367. 10.1002/jbmr.1588, 3415623, 22407806.
29. Cunningham-Rundles S, Ahrné S, Johann-Liang R, Abuav R, Dunn-Navarra AM, Grassey C, Bengmark S, Cervia JS. Effect of probiotic bacteria on microbial host defense, growth, and immune function in human immunodeficiency virus type-1 infection. Nutrients 2011, 3:1042-1070. 10.3390/nu3121042, 3260491, 22292110.
30. Nunnari G, Coco C, Pinzone MR, Pavone P, Berretta M, Di Rosa M, Schnell M, Calabrese G, Cacopardo B. The role of micronutrients in the diet of HIV-1-infected individuals. Front Biosci (Elite Ed) 2012, 4:2442-2456.
31. Brown TT, Qaqish RB. Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review. AIDS 2006, 20:2165-2174. 10.1097/QAD.0b013e32801022eb, 17086056.
32. Haug CJ, Aukrust P, Haug E, Mørkrid L, Müller F, Frøland SS. Severe deficiency of 1,25-dihydroxyvitamin D3 in human immunodeficiency virus infection: association with immunological hyperactivity and only minor changes in calcium homeostasis. J Clin Endocrinol Metab 1998, 83:3832-3838. 10.1210/jc.83.11.3832, 9814454.
33. Conrado T, Miranda-Filho Dde B, Bandeira F. Vitamin D deficiency in HIV-infected individuals: one more risk factor for bone loss and cardiovascular disease?. Arq Bras Endocrinol Metabol 2010, 54:118-122.
34. Grund B, Peng G, Gibert CL, Hoy JF, Isaksson RL, Shlay JC, Martinez E, Reiss P, Visnegarwala F, Carr AD, , . INSIGHT SMART Body Composition Substudy Group, INSIGHT SMART Body Composition Substudy Group Continuous antiretroviral therapy decreases bone mineral density. AIDS 2009, 23:1519-1529. 10.1097/QAD.0b013e32832c1792, 2748675, 19531929, INSIGHT SMART Body Composition Substudy Group, INSIGHT SMART Body Composition Substudy Group.
35. Bolland MJ, Grey A, Horne AM, Briggs SE, Thomas MG, Ellis-Pegler RB, Gamble GD, Reid IR. Stable bone mineral density over six years in HIV-infected men treated with highly active anti-retroviral therapy (HAART). Clin Endocrinol (Oxf) in press.
36. Jain RG, Lenhard JM. Select HIV protease inhibitors alter bone and fat metabolism ex vivo. J Biol Chem 2002, 277:19247-19250. 10.1074/jbc.C200069200, 11937496.
37. Tan BM, Nelson RP, James-Yarish M, Emmnueal P, Schurman SJ. Bone metabolism in children with human immunodeficiency virus infection receiving highly active anti-retroviral therapy including a protease inhibitor. J Pediatr 2001, 139:447-451. 10.1067/mpd.2001.117005, 11562628.
38. Fernández-Rivera J, García R, Lozano F, Macías J, García-García JA, Mira JA, Corzo JE, Gómez-Mateos J, Rueda A, Sánchez-Burson J, Pineda JA. Relationship between low bone mineral density and highly active antiretroviral therapy including protease inhibitors in HIV-infected patients. HIV Clin Trials 2003, 4:337-346. 10.1310/4X0H-UVMJ-BHYW-CPFB, 14583850.
39. McComsey GA, Tebas P, Shane E, Yin MT, Overton ET, Huang JS, Aldrovandi GM, Cardoso SW, Santana JL, Brown TT. Bone disease in HIV infection: a practical review and recommendations for HIV care providers. Clin Infect Dis 2010, 51:937-946. 10.1086/656412, 3105903, 20839968.
40. Yin MT, Overton ET. Increasing clarity on bone loss associated with antiretroviral initiation. J Infect Dis 2011, 203:1705-1707. 10.1093/infdis/jir184, 21606527.
41. Liu AY, Vittinghoff E, Sellmeyer DE, Irvin R, Mulligan K, Mayer K, Thompson M, Grant R, Pathak S, O'Hara B, Gvetadze R, Chillag K, Grohskopf L, Buchbinder SP. Bone mineral density in HIV-negative men participating in a tenofovir pre-exposure prophylaxis randomized clinical trial in San Francisco. PLoS One 2011, 6:e23688. 10.1371/journal.pone.0023688, 3163584, 21897852.
42. Torti C, Mazziotti G, Soldini PA, Focà E, Maroldi R, Gotti D, Carosi G, Giustina A. High prevalence of radiological vertebral fractures in HIV-infected males. Endocr 2012, 41:512-517.
43. Gazzaruso C. An increased risk for fractures: another cause of frailty in HIV-infected subjects. Endocrine 2012, 41:347-349. 10.1007/s12020-012-9640-0, 22399153.
44. Calmy A, Fux CA, Norris R, Vallier N, Delhumeau C, Samaras K, Hesse K, Hirschel B, Cooper DA, Carr A. Low bone mineral density, renal dysfunction, and fracture risk in HIV infection: a cross-sectional study. J Infect Dis 2009, 200:1746-1754. 10.1086/644785, 19874178.
45. Mondy K, Yarasheski K, Powderly WG, Whyte M, Claxton S, DeMarco D, Hoffmann M, Tebas P. Longitudinal evolution of bone mineral density and bone markers in human immunodeficiency virus-infected individuals. Clin Infect Dis 2003, 36:482-490. 10.1086/367569, 12567307.
46. Thomas J, Doherty SM. HIV infection-a risk factor for osteoporosis. J Acquir Immune Defic Syndr 2003, 33:281-291. 10.1097/00126334-200307010-00001, 12843738.
47. Bolland MJ, Grey AB, Gamble GD, Reid IR. CLINICAL Review # : low body weight mediates the relationship between HIV infection and low bone mineral density: a meta-analysis. J Clin Endocrinol Metab 2007, 92:4522-4528. 10.1210/jc.2007-1660, 17925333.
48. Dougkas A, Reynolds CK, Givens ID, Elwood PC, Minihane AM. Associations between dairy consumption and body weight: a review of the evidence and underlying mechanisms. Nutr Res Rev 2011, 24:72-95.
49. Warensjö E, Byberg L, Melhus H, Gedeborg R, Mallmin H, Wolk A, Michaëlsson K. Dietary calcium intake and risk of fracture and osteoporosis: prospective longitudinal cohort study. BMJ 2011, 342:d1473. 10.1136/bmj.d1473, 3101331, 21610048.
50. Sharma A, Flom PL, Weedon J, Klein RS. Prospective study of bone mineral density changes in aging men with or at risk for HIV infection. AIDS 2010, 24:2337-2345. 2936812, 20683316.
51. Etminani-Esfahani M, Khalili H, Soleimani N, Jafari S, Abdollahi A, Khazaeipour Z, Gholami K. Serum vitamin D concentration and potential risk factors for its deficiency in HIV positive individuals. Curr HIV Res 2012, 10:165-170. 10.2174/157016212799937272, 22329521.
52. Petta S, Ferraro D, Cammà C, Cabibi D, Di Cristina A, Di Marco V, Di Stefano R, Grimaudo S, Mazzola A, Levrero M, Scazzone C, Craxì A. Vitamin D levels and IL28B polymorphisms are related to rapid virological response to standard of care in genotype 1 chronic hepatitis C. Antivir Ther 2012, in press.
53. Lo Re V, Guaraldi G, Leonard MB, Localio AR, Lin J, Orlando G, Zirilli L, Rochira V, Kostman JR, Tebas P. Viral hepatitis is associated with reduced bone mineral density in HIV-infected women but not men. AIDS 2009, 23:2191-2198. 10.1097/QAD.0b013e32832ec258, 2837269, 19779322.